Key terms
About ZYXI
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ZYXI news
Apr 17
3:59am ET
RBC Capital Remains a Buy on Zynex (ZYXI)
Mar 14
2:02am ET
Zynex Inc. at a Crossroads: $60 Million Convertible Notes Pose Liquidity and Dilution Risks
Mar 09
9:55am ET
Short Report: Bearish positions reduced after contrasting C3.ai and Figs results
Mar 08
7:27am ET
Zynex (ZYXI) Receives a Buy from RBC Capital
Mar 01
7:27am ET
RBC Capital Remains a Buy on Zynex (ZYXI)
Mar 01
6:27am ET
Buy Rating Affirmed for Zynex on Strong Growth Prospects and Financial Health
Mar 01
6:23am ET
Zynex price target raised to $21 from $20 at H.C. Wainwright
Feb 29
4:03pm ET
Zynex announces additional $20M share repurchase program
Feb 29
4:02pm ET
Zynex reports Q4 EPS 4c, consensus 17c
Feb 06
9:16am ET
Zynex receives FDA clearance for next generation NMES device
No recent press releases are available for ZYXI
ZYXI Financials
Key terms
Ad Feedback
ZYXI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ZYXI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range